Corneal confocal microscopy identifies small fibre damage and progression of diabetic neuropathy

Autor: Jan Hoong Ho, Ioannis N. Petropoulos, Shaishav Dhage, Andrew Atkinson, Uazman Alam, Maryam Ferdousi, Safwaan Adam, Georgios Ponirakis, Handrean Soran, Shazli Azmi, Alise Kalteniece, Maria Jeziorska, Andrew Marshall, Rayaz A. Malik
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Diabetic neuropathy
Urinary albumin
Nerve Fibers/pathology
Body Mass Index
Cornea
chemistry.chemical_compound
0302 clinical medicine
Nerve Fibers
Diabetic Neuropathies
Diabetes complications
Diabetic Neuropathies/blood
Multidisciplinary
Microscopy
Confocal/methods

Microscopy
Confocal

Quantitative sensory testing
Diabetes
Middle Aged
Cornea/pathology
Cholesterol
LDL/blood

Disease Progression
Medicine
Diabetes Mellitus
Type 2/blood

Adult
medicine.medical_specialty
Glycated Hemoglobin A/metabolism
Science
030209 endocrinology & metabolism
Article
03 medical and health sciences
Vibration perception
Diabetes mellitus
Ophthalmology
medicine
Humans
Aged
Glycated Hemoglobin
Creatinine
Analysis of Variance
Autonomic nerve
business.industry
Diabetes Mellitus
Type 1/blood

Cholesterol
LDL

medicine.disease
Peripheral neuropathy
Diabetes Mellitus
Type 1

chemistry
Diabetes Mellitus
Type 2

business
030217 neurology & neurosurgery
Zdroj: SCIENTIFIC REPORTS
Scientific Reports
Dhage, S, Ferdousi, M, Adam, S, Ho, J H, Kalteniece, A, Azmi, S, Alam, U, Ponirakis, G, Petropoulos, I, Atkinson, A J, Marshall, A, Jeziorska, M, Soran, H & Malik, R A 2021, ' Corneal confocal microscopy identifies small fibre damage and progression of diabetic neuropathy ', Scientific Reports, vol. 11, no. 1, 1859 . https://doi.org/10.1038/s41598-021-81302-8
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
DOI: 10.1038/s41598-021-81302-8
Popis: Accurately quantifying the progression of diabetic peripheral neuropathy is key to identify individuals who will progress to foot ulceration and to power clinical intervention trials. We have undertaken detailed neuropathy phenotyping to assess the longitudinal utility of different measures of neuropathy in patients with diabetes. Nineteen patients with diabetes (age 52.5 ± 14.7 years, duration of diabetes 26.0 ± 13.8 years) and 19 healthy controls underwent assessment of symptoms and signs of neuropathy, quantitative sensory testing, autonomic nerve function, neurophysiology, intra-epidermal nerve fibre density (IENFD) and corneal confocal microscopy (CCM) to quantify corneal nerve fibre density (CNFD), branch density (CNBD) and fibre length (CNFL). Mean follow-up was 6.5 years. Glycated haemoglobin (p = 0.04), low-density lipoprotein-cholesterol (LDL-C) (p = 0.0009) and urinary albumin creatinine ratio (p p = 0.03), neuropathy disability score (p = 0.04), vibration perception threshold (p = 0.02), cold perception threshold (p = 0.006), CNFD (p = 0.03), CNBD (p p p = 0.04), sural (p = 0.02) and peroneal motor nerve conduction velocity (p = 0.03) deteriorated significantly. Change (∆) in CNFL correlated with ∆CPT (p = 0.006) and ∆Expiration/Inspiration ratio (p = 0.002) and ∆IENFD correlated with ∆CNFD (p = 0.005), ∆CNBD (p = 0.02) and ∆CNFL (p = 0.01). This study shows worsening of diabetic neuropathy across a range of neuropathy measures, especially CCM, despite an improvement in HbA1c and LDL-C. It further supports the utility of CCM as a rapid, non-invasive surrogate measure of diabetic neuropathy.
Databáze: OpenAIRE